Apella Announces $21 Million Series A Funding to Digitize the Operating Room

Funding to Support Development and Deployment of AI Technology Platform for Surgery

SAN FRANCISCO, December 20, 2021–(BUSINESS WIRE)–Apella, a technology company dedicated to improving surgery, has announced completion of $21 million in Series A funding. The financing was led by Casdin Capital, who was joined by Vensana CapitalPFM Health SciencesTwine VenturesUpside Partnership, and Operator Partners as well as a number of notable individual investors.

“Apella believes that every patient deserves the best possible outcome from surgery,” commented David Schummers, co-founder and CEO of Apella. “Our technology is aimed at helping each member of the surgical team to do their best job.”

Apella’s initial products include sensors installed in the operating room and harness a variety of artificial intelligence approaches to collect and analyze new data about surgery. This data contributes to applications targeted at improving hospital operations, surgical quality, staff training and real-time decision making with the overall goal of improving the quality of surgical care.

“At Apella, we know that you can’t improve what you can’t measure,” continued Schummers. “We are developing systematic methods for continuous improvement that can be applied to all types of surgeries and medical procedures.”

The funding will support expanded implementation of Apella’s technology with hospital partners. It will also allow Apella to grow its team and develop new applications based on its core platform and computer vision and machine learning capabilities.

“Apella is creating the operating system for the operating room,” commented Justin Klein, Managing Partner of Vensana Capital. “The company’s technology can create a true system of record by capturing data that is unbiased, reliable, and increases in value over time. The Apella team is very experienced in technology and well grounded in the voice of the customer, and we are thrilled to work with them as they bring this technology to market.”

About Apella

Apella is a technology company for better surgery. Every patient deserves the opportunity to have the best possible surgical experience. Apella aims to make that happen by digitizing the operating room. The Company’s technology harnesses artificial intelligence to create a systematic method for process improvement and quality control in surgery. Learn more at apella.io.

Contact:

Holly Amaya
(619) 573-7224

About Peter Coffaro 477 Articles
A growth-driven and strategic executive, Peter Coffaro commands more than 25 years of progressive management success within the medical device industry. Recognized by the World Journal of Orthopedics, Exponential Healthtech, and MedReps.com as one of the top medical sales influencers in the industry; he has 10 years of combined sales management experience and has held positions as a Director, General Manager, Distributor, and Vice President. Peter has worked for some of the top orthopedic companies in the world - Zimmer, DePuy, and Stryker. He is also the founder of OrthoFeed: a popular blog that covers digital orthopedic news and emerging medical technologies. Peter is a three-time Hall of Fame award winner at Johnson and Johnson and has an extensive background in organizational development, business development, sales management, digital marketing, and professional education. Peter holds a B.S. degree in Biology and Chemistry from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.


*


This site uses Akismet to reduce spam. Learn how your comment data is processed.